We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Regeneron Files for EUA for COVID-19 Monoclonal Antibody
Regeneron Files for EUA for COVID-19 Monoclonal Antibody
Regeneron Pharmaceuticals submitted a request for Emergency Use Authorization (EUA) for its COVID-19 antibody treatment Thursday, just one day after Eli Lilly filed for authorization of its own monoclonal antibody.